BlackRock Institutional Trust’s Microbot Medical MBOT Stock Holding History

BlackRock Institutional Trust’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$360K	Buy	3,936 +574	+17%	+$72.5K	﹤0.01%	3508
2016 Q3	$617K	Buy	3,362 +1,631	+94%	+$213K	﹤0.01%	3433
2016 Q2	$94K	Hold	1,731	–	–	﹤0.01%	3717
2016 Q1	$731K	Hold	1,731	–	–	﹤0.01%	3371
2015 Q4	$1.17M	Hold	1,731	–	–	﹤0.01%	3289
2015 Q3	$1.12M	Buy	1,731 +15	+0.9%	+$11.4K	﹤0.01%	3305
2015 Q2	$1.5M	Buy	1,716 +11	+0.6%	+$12.9K	﹤0.01%	3229
2015 Q1	$2.82M	Buy	1,705 +42	+3%	+$75K	﹤0.01%	2960
2014 Q4	$2.53M	Buy	1,663 +25	+2%	+$45.4K	﹤0.01%	3004
2014 Q3	$3.34M	Sell	1,638 -150	-8%	-$396K	﹤0.01%	2853
2014 Q2	$5.88M	Buy	1,788 +62	+4%	+$143K	﹤0.01%	2709
2014 Q1	$3.75M	Buy	1,726 +251	+17%	+$600K	﹤0.01%	2894
2013 Q4	$2.94M	Buy	1,475 +471	+47%	+$997K	﹤0.01%	3009
2013 Q3	$2.73M	Buy	1,004 +84	+9%	+$228K	﹤0.01%	2987
2013 Q2	$2.46M	Buy	+920	New	+$2.59M	﹤0.01%	2991

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

DSC

Duncker Streett & Co St. Louis, Missouri $526M AUM 22.2% 1-Year Est. Return

BlackRock Institutional Trust's MBOT Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Microbot Medical (MBOT) stake by 17% in Q4 2016, buying an estimated $72.5K and bringing the position to 3,936 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #3508.

BlackRock Institutional Trust first reported a position in MBOT in Q2 2013 and has held it in 15 quarters since. The position peaked at $5.88M in Q2 2014. 18 funds tracked by Wall St. Rank hold MBOT as of Q4 2016.

BlackRock Institutional Trust held 3,936 shares of Microbot Medical worth $360K as of Q4 2016.
BlackRock Institutional Trust bought 574 Microbot Medical shares in Q4 2016, an estimated $72.5K.
Microbot Medical made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3508 holding.
BlackRock Institutional Trust first reported a position in Microbot Medical in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Microbot Medical position peaked at $5.88M in Q2 2014.
18 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.